Navigation Links
Par Pharmaceutical Enters Into Agreement With Reliant Pharmaceuticals to Settle Patent Litigation Over Rythmol(R) SR
Date:4/21/2009

ute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. To the extent any statements made in this news release contain information that is not historical, these statements are essentially forward-looking and, as such, are subject to known and unknown risks, uncertainties and contingencies, many of which are beyond the control of the Company, which could cause actual results and outcomes to differ materially from those expressed herein. Risk factors that might affect such forward-looking statements include those set forth in Item 1A of the Company's Annual Report on Form 10-K for the year ended December 31, 2008, in other of the Company's filings with the SEC from time to time, including Current Reports on Form 8-K, and on general industry and economic conditions. Any forward-looking statements included in this news release are made as of the date hereof only, based on information available to the Company as of the date hereof, and, subject to any applicable law to the contrary, the Company assumes no obligation to update any forward-looking statements.


'/>"/>
SOURCE Par Pharmaceutical Companies, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Mylan Commences Tender Offers and Consent Solicitations for Its 5.750% Senior Notes Due 2010 and 6.375% Senior Notes Due 2015 in Connection With Its Proposed Acquisition of Mercks Generic Pharmaceutical Business
2. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
3. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
4. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
5. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Adipex-P(R)
6. National Pharmaceutical Council Announces New Strategic Focus, Search for New Leadership
7. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Coreg(R)
8. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
9. Par Pharmaceutical Files Form 10-K for 2006 -- Company to Hold First Analysts Meeting September 28, 2007
10. Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
11. Pharmaceutical Manufacturing Quality: Optimizing Your Internal Process for FDA Compliance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/2/2015)... MedixSafe Vanguard 2 is available, a full line of ... security demands – from stocking a large inventory at ... limited narcotics from falling into the wrong hands. , ... wireless connection to your network and mobile devices that ... Vanguard 2 provides tracking narcotics inventory for ...
(Date:4/1/2015)... April 02, 2015 Robins & Morton ... Living Media Services Building for the New T-Mobile Financial ... five months, including complete demolition of the interior systems, ... addition of 250 parking spaces to accommodate employees. ... his firm was excited to develop such a unique ...
(Date:4/1/2015)... 01, 2015 Levi's® Stadium , located ... the United States. The San Francisco 49ers from the National ... only last year, Levi’s Stadium has been the home of ... been held here thus far include a game from the ... Kings and San Jose Sharks, Wrestlemania 31 and an International ...
(Date:4/1/2015)... Bird B Gone, the leader in bird control ... a complete line of Bird Netting Hardware ... quickly, safely and efficiently. , Having the right hardware ... installation. It’s important to determine exactly what hardware will ... This includes deciding whether to use all stainless steel ...
(Date:4/1/2015)... (PRWEB) April 01, 2015 Baby Bellies ... providing the latest information on the top products and ... set the Guinness World Records title for "Mommy Moments” ... of the 1st annual Baby Bellies & Beyond Expo ... and the Guinness World Record will commence at 11:00am ...
Breaking Medicine News(10 mins):Health News:MedixSafe Introduces New High Tech Narcotics Security Solution - Vanguard 2 2Health News:Robins & Morton Transforms Former Southern Living Media Services Building for New T-Mobile Financial Care Call Center 2Health News:Levi's® Stadium Tickets for Super Bowl 50, Kenny Chesney & Jason Aldean, One Direction, Taylor Swift and Luke Bryan Available at Discounted Prices at TicketDown.com 2Health News:Levi's® Stadium Tickets for Super Bowl 50, Kenny Chesney & Jason Aldean, One Direction, Taylor Swift and Luke Bryan Available at Discounted Prices at TicketDown.com 3Health News:Bird B Gone Now Carries Complete Bird Netting Hardware 2Health News:Bird B Gone Now Carries Complete Bird Netting Hardware 3Health News:Baby Bellies & Beyond Attempts To Break Guinness World Records For “Mommy Moments” Largest Gathering Of Pregnant Women April 19 Outside Florida Hotel & Conference Center 2Health News:Baby Bellies & Beyond Attempts To Break Guinness World Records For “Mommy Moments” Largest Gathering Of Pregnant Women April 19 Outside Florida Hotel & Conference Center 3
... and TAMPA, Fla., April 1 Stem Cell Biotherapy ... Los Angeles County Superior Court against the Company,s Co-Founder ... among other things conduct by Nabavi giving rise to ... as a medical doctor, practiced medicine without a license, ...
... April 1 Heavenly Essence, Inc. announces a ... for the ethnic market.The company,s flagship product line, ... of Pure,ity Shampoo and Pure,ity Conditioner, in two ... natural botanicals and hypo-allergenic ingredients, they are now ...
... Call Scheduled for Today at 5:00 p.m. EDT -- ... Pharmaceuticals, Inc. (Nasdaq: SNSS ) today announced ... investors providing for a private placement of up to ... of units consisting of convertible preferred stock and common ...
... were 63 percent more likely to develop the disease, study ... to high levels of traffic pollution have an increased risk ... analyzed the records of 90,000 women in the Nurses Health ... each woman,s home and the nearest major roadways. The results ...
... CitiusTech, a leading provider,of healthcare technology solutions and ... comprehensive program to enable healthcare ISVs to meet,CCHIT requirements ... adoption timeline of 2012 set as part of the ... Act presents a tremendous opportunity for healthcare ISVs to,increase ...
... Hepatology explore the ways that hepatitis B virus ... patients, bodies. Hepatology is a journal published by ... for the Study of Liver Diseases (AASLD). The articles are ... , Both HBV and HCV are global health problems. They ...
Cached Medicine News:Health News:Stem Cell Biotherapy Sues Casey Nabavi, Co-Founder and Former President, for Conduct Resulting in Claims by SCB Patients Against Nabavi, Embezzling Money and Converting Other Assets Belonging to SCB and for Wrongfully Establishing Cellulogix Biosciences t 2Health News:Sunesis Pharmaceuticals Announces Up To $43.5 Million Financing 2Health News:Sunesis Pharmaceuticals Announces Up To $43.5 Million Financing 3Health News:Sunesis Pharmaceuticals Announces Up To $43.5 Million Financing 4Health News:Sunesis Pharmaceuticals Announces Up To $43.5 Million Financing 5Health News:Sunesis Pharmaceuticals Announces Up To $43.5 Million Financing 6Health News:Living Near Major Road May Boost Rheumatoid Arthritis Risk 2Health News:CitiusTech Launches Vantage 2012 Program to Enable Healthcare ISVs to Meet CCHIT Requirements & Capture HITECH Act Related Growth Opportunities 2Health News:New studies examine elimination of hepatitis B and C 2
(Date:4/1/2015)... 1, 2015  Hologic, Inc. (NASDAQ: HOLX ) ... 2.00% Convertible Exchange Senior Notes due 2037 (CUSIP No. ... Company, the trustee, paying agent and conversion agent for ... notes.  This conversion right is subject to the terms ... of December 10, 2007, as supplemented by the second ...
(Date:4/1/2015)... 2015  The first national study to look ... treat attention-deficit/hyperactivity disorder (ADHD) among children ages 4-17 ... with ADHD were receiving behavioral therapy in 2009-2010 ... Prevention (CDC) study, "Treatment of Attention-Deficit/Hyperactivity Disorder among ... in The Journal of Pediatrics provides ...
(Date:4/1/2015)... , April 1, 2015  The fairness of the ... "Company") by Teva Pharmaceutical Industries ("Teva") is being investigated ... law firm.  The investigation focuses on possible breaches of ... Board of Directors of ASPX for agreeing to sell ... Company announced a definitive agreement for Teva to acquire ...
Breaking Medicine Technology:Hologic Delivers Notice that Holders of 2.00% Convertible Exchange Senior Notes Due 2037 are Eligible to Convert 2CDC publishes first national study on use of behavioral therapy, medication and dietary supplements for ADHD in children 2CDC publishes first national study on use of behavioral therapy, medication and dietary supplements for ADHD in children 3CDC publishes first national study on use of behavioral therapy, medication and dietary supplements for ADHD in children 4WeissLaw LLP: Auspex Pharmaceuticals Inc. Acquisition By Teva Pharmaceutical Industries May Not Be In The Best Interest of ASPX Shareholders 2
... Israel--(BUSINESS WIRE)--Jun 14, 2007 - Can-Fite,BioPharma (TASE:CFBI), a ... Exchange, proceeds with the development of its,third drug ... is currently,in clinical trials and CF102, which is ... the EUALR annual congress of,rheumatology in-vitro and in ...
... of SLE,disease at 52 Weeks and demonstrated ... ROCKVILLE, Md., June 14, 2007 /PRNewswire-FirstCall/ -- ... of Phase 2,trial data demonstrating that LymphoStat-B(R) ... was well tolerated and improved quality of ...
Cached Medicine Technology:Can-Fite Proceeds with Development of Third Drug; Progress in,Development of CF502 Will Be Presented at the Annual European,Congress of Rheumatology 2Human Genome Sciences Reports That a Phase 2 Study of LymphoStat-B,Showed Significant Reductions in Disease Activity in Patients with,Active Systemic Lupus Erythematosus 2Human Genome Sciences Reports That a Phase 2 Study of LymphoStat-B,Showed Significant Reductions in Disease Activity in Patients with,Active Systemic Lupus Erythematosus 3Human Genome Sciences Reports That a Phase 2 Study of LymphoStat-B,Showed Significant Reductions in Disease Activity in Patients with,Active Systemic Lupus Erythematosus 4Human Genome Sciences Reports That a Phase 2 Study of LymphoStat-B,Showed Significant Reductions in Disease Activity in Patients with,Active Systemic Lupus Erythematosus 5Human Genome Sciences Reports That a Phase 2 Study of LymphoStat-B,Showed Significant Reductions in Disease Activity in Patients with,Active Systemic Lupus Erythematosus 6Human Genome Sciences Reports That a Phase 2 Study of LymphoStat-B,Showed Significant Reductions in Disease Activity in Patients with,Active Systemic Lupus Erythematosus 7Human Genome Sciences Reports That a Phase 2 Study of LymphoStat-B,Showed Significant Reductions in Disease Activity in Patients with,Active Systemic Lupus Erythematosus 8
Open wire loops decrease the chance of interfering with instruments, Designed to retract the eyelid during ophthalmic microsurgery or minor office procedures...
Smooth, round edges allow for safe manipulation within the eye. 1.1mm wide gradually tapers to .50 mm wide. 45, 1.1mm wide, gradually tapers to .50mm wide....
Designed to lift corneal cap/flap during corneal lamellar surgery...
Pre-expanded for convenience; no need to pre-soak and fan. Lint-free PVAmaterial...
Medicine Products: